Comparison of beta peak detection algorithms for data-driven deep brain stimulation programming strategies in Parkinson’s disease
Oscillatory activity within the beta frequency range (13-30 Hz) serves as a Parkinson's disease biomarker for tailoring deep brain stimulation (DBS) treatments. Currently, identifying clinically relevant beta signals, specifically frequencies of peak amplitudes within the beta spectral band, is a subjective process. To inform potential strategies for objective clinical decision making, we assessed algorithms for identifying beta peaks and devised a standardized approach for both research and clinical applications. Employing a novel monopolar referencing strategy, we utilized a brain sensing device to measure beta peak power across distinct contacts along each DBS electrode implanted in the subthalamic nucleus. We then evaluated the accuracy of ten beta peak detection algorithms against a benchmark established by expert consensus. The most accurate algorithms, all sharing similar underlying algebraic dynamic peak amplitude thresholding approaches, matched the expert consensus in performance and reliably predicted the clinical stimulation parameters during follow-up visits. These findings highlight the potential of algorithmic solutions to overcome the subjective bias in beta peak identification, presenting viable options for standardizing this process. Such advancements could lead to significant improvements in the efficiency and accuracy of patient-specific DBS therapy parameterization.
Authors
- Michelle Case
- Drew S. Kern (ORCID: https://orcid.org/0000-0001-7317-3787)
- Abbey Holt-Becker
- Robert S. Raike
- Erin Radcliffe
- Sunderland Baker (ORCID: https://orcid.org/0000-0002-7975-0554)
- John A. Thompson (ORCID: https://orcid.org/0000-0003-2991-5194)
- Caleb Zarns
- Steven Ojemann (ORCID: https://orcid.org/0000-0002-6473-2249)
- Alexander J. Baumgartner (ORCID: https://orcid.org/0000-0002-0009-2756)
- Daniel R. Kramer (ORCID: https://orcid.org/0000-0003-4551-2977)
Institutions
- Pennsylvania State University (US)
- Medtronic (United States) (US)
- University of Colorado Anschutz Medical Campus (US)
Publication Details
- Journal
- npj Parkinson s Disease
- Published
- 2024-08-09
- DOI
- https://doi.org/10.1038/s41531-024-00762-7
- Citations
- 4
- Primary Topic
- Neurological disorders and treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.48
Funders
- National Science Foundation
- Medtronic
- National Institute of Neurological Disorders and Stroke